Develops and sells bone graft materials and spinal implant systems used by orthopedic spine surgeons, neurosurgeons and other orthopedic and wound-care specialists.
The company sells biologics and spinal products to hospitals when used in surgery, and invoices resellers when products ship or are delivered. License agreements bring upfront fees and royalties based on product sales.
10-K for FY2025, filed Mar 31, 2026For each surgical procedure, the sales agent reports use of the product by the hospital and, as soon as practicable thereafter, ensures…View ↗
Additionally, the Company sells product directly to domestic and international stocking resellers, original equipment manufacturer…View ↗
The Company has a license agreement which grants an exclusive, nontransferable, non-sublicensable, royalty bearing right to manufacture and…View ↗
10-K for FY2025, filed Mar 31, 2026
FY2025 revenue by product or service ↗$133.9M
10-K for FY2025, filed Mar 31, 2026
$133.9M ↗| Segment | Share | Revenue | How money arrives |
|---|---|---|---|
|
Orthobiologics
Sold outright
10-K for FY2025, filed Mar 31, 2026 |
54%
FY2022: 81%
|
Orthobiologics, FY2025
$72.9M Sources
|
Sold outright |
|
Spinal Implant
Sold outright
10-K for FY2025, filed Mar 31, 2026 |
32%
FY2022: 19%
|
Spinal Implant, FY2025
$42.3M Sources
|
Sold outright |
|
License Revenue
Licensed
10-K for FY2025, filed Mar 31, 2026 |
14% |
License Revenue, FY2025
$18.7M Sources
|
Licensed |
U.S. hospitals are served through commissioned agents and stocking distributors, with agents accessing hospital networks and purchasing groups. The company also sells to domestic and international resellers and serves international markets through distribution partners.
10-K for FY2025, filed Mar 31, 2026We promote our products in the United States through independent distributors and stocking agents, supported by direct employees. We have…View ↗
Additionally, the Company sells product directly to domestic and international stocking resellers, original equipment manufacturer…View ↗
We distribute our products in the United States through an extensive distribution network of commissioned independent sales agents and…View ↗
Our international footprint includes distribution partners in Europe, Canada, Mexico, South America, and certain Pacific region countries.View ↗
Yes. It kept 4 cents of every revenue dollar as net income in FY2025 and turned 8 cents into free cash flow.
10-Q for Q3 FY2026, filed Nov 16, 2026
−$3.6MView ↗
10-Q for Q3 FY2026, filed Nov 16, 2026
Open tableView ↗
8-K, filed Aug 11, 2026
Reflecting lower-than-expected biologics revenue in the second quarter, as well as ongoing headwinds related to its amnio product line…View ↗
8-K, filed May 13, 2026
Increased full-year 2026 revenue guidance to a range of $101 million to $105 million, from $95 million to $99 million previously, to…View ↗
8-K, filed Apr 13, 2026
Xtant entered into the Distribution Agreement with Dilon on April 10, 2026, and in connection therewith, hired approximately 20 Dilon sales…View ↗
Growing. Revenue grew 2.4x in 4 years, from $55.3M in FY2021 to $133.9M in FY2025, about 25% a year.
Broader biologics applications
The older overview centered on spinal procedures; the latest also describes biologics for trauma, foot and ankle, sports medicine, joint replacement, surgical repair and wound care.
10-K for FY2022, filed Mar 7, 2023 10-K for FY2025, filed Mar 31, 2026Xtant Medical Holdings, Inc. is a global medical technology company focused on the design, development, and commercialization of a…View ↗
Xtant Medical Holdings, Inc. is a global medical technology company focused on the design, development, and commercialization of a…View ↗
Exited international hardware operations
The older report described international product sales through partners; the latest says Xtant sold its international hardware business while continuing to serve international markets through distribution partners.
10-K for FY2022, filed Mar 7, 2023 10-K for FY2025, filed Mar 31, 2026We promote and sell our products in the United States through independent distributors and stocking agents, supported by direct employees.…View ↗
Competes with Medtronic, Johnson and Johnson, Bioventus, Globus Medical, OrthoFix Medical, Alphatec Holdings, Highridge, SI-Bone, AlloSource International, LifeNet Health, and MTF Biologics
10-K for FY2025, filed Mar 31, 2026There are various public and private organizations that offer both orthobiologics and fixation products to their customers, including our…View ↗
Loading...